Browse hierarchy: [Hematology (HE)](/submissions/HE) → [Subpart H — Hematology Kits and Packages](/submissions/HE/subpart-h%E2%80%94hematology-kits-and-packages) → [21 CFR 864.7297](/submissions/HE/subpart-h%E2%80%94hematology-kits-and-packages/864.7297) → SAC — Adamts13 Activity Test System

# SAC · Adamts13 Activity Test System

_Hematology · 21 CFR 864.7297 · Class 2_

**Canonical URL:** https://fda.innolitics.com/submissions/HE/subpart-h%E2%80%94hematology-kits-and-packages/SAC

## Overview

- **Product Code:** SAC
- **Device Name:** Adamts13 Activity Test System
- **Regulation:** [21 CFR 864.7297](/submissions/HE/subpart-h%E2%80%94hematology-kits-and-packages/864.7297)
- **Device Class:** 2
- **Review Panel:** [Hematology](/submissions/HE)

## Identification

The Technozym ADAMTS13 Activity assay is an enzyme-linked immunosorbent assay (ELISA) intended for the qualitative determination of ADAMTS13 activity in platelet-poor human citrated plasma. It is used in conjunction with other clinical and laboratory findings as an aid in the diagnosis of thrombotic thrombocytopenic purpura (TTP) in adult and pediatric patients being evaluated for thrombotic microangiopathy (TMA).

## Classification Rationale

Class II with special controls. The device is classified as Class II because general controls alone are insufficient to provide reasonable assurance of safety and effectiveness, but the risks can be mitigated by special controls including design verification, validation, and specific labeling requirements.

## Recent Cleared Devices (1 of 1)

| Record | Device Name | Applicant | Decision Date | Decision |
| --- | --- | --- | --- | --- |
| [DEN230024](https://fda.innolitics.com/submissions/HE/subpart-h%E2%80%94hematology-kits-and-packages/SAC/DEN230024.md) | Technozym ADAMTS13 Activity | Technoclone Herstellung Von Diagnostika Und Arzneimitteln GM | Feb 28, 2024 | DENG |

## Top Applicants

- Technoclone Herstellung Von Diagnostika Und Arzneimitteln GM — 1 clearance

---

**Source:** [https://fda.innolitics.com/submissions/HE/subpart-h%E2%80%94hematology-kits-and-packages/SAC](https://fda.innolitics.com/submissions/HE/subpart-h%E2%80%94hematology-kits-and-packages/SAC)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com